APA (7th ed.) Citation

Brewer, M., Angioli, R., Scambia, G., Lorusso, D., Terranova, C., Panici, P. B., . . . Nicodemus, C. (2020). Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study. Gynecologic Oncology, 156(3), 523. https://doi.org/10.1016/j.ygyno.2019.12.024

Chicago Style (17th ed.) Citation

Brewer, Molly, et al. "Front-line Chemo-immunotherapy with Carboplatin-paclitaxel Using Oregovomab Indirect Immunization in Advanced Ovarian Cancer: A Randomized Phase II Study." Gynecologic Oncology 156, no. 3 (2020): 523. https://doi.org/10.1016/j.ygyno.2019.12.024.

MLA (9th ed.) Citation

Brewer, Molly, et al. "Front-line Chemo-immunotherapy with Carboplatin-paclitaxel Using Oregovomab Indirect Immunization in Advanced Ovarian Cancer: A Randomized Phase II Study." Gynecologic Oncology, vol. 156, no. 3, 2020, p. 523, https://doi.org/10.1016/j.ygyno.2019.12.024.